Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing

Choosing wisely: Diagnosis and staging of stomach and colorectal cancer

Rectal cancer in Latin America, screening and surgery

The challenge of detecting NTRK fusions across tumour types

Shaping the future of metastasis - ecancer investigates

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma

KATHERINE trial updates for HER2-positive breast cancer

PARP inhibitors for metastatic breast cancer

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours

MEDIOLA: Olaparib and durvalumab for germline BRCA-mutated metastatic breast cancer